476. Deputy Albert Dolan asked the Minister for Health whether her Department has considered measures to improve access to spare emergency medicines such as adrenaline auto-injectors in schools for use in cases of suspected but undiagnosed anaphylaxis; and if she will make a statement on the matter. [23376/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Albert Dolan .
196 questions match, newest first.
477. Deputy Albert Dolan asked the Minister for Health whether her Department is engaging with the Department of Education and Youth regarding preparedness in schools to respond to severe allergic reactions and other medical emergencies; and if she will make a statement on the matter. [23377/26]
1750. Deputy Albert Dolan asked the Minister for Health the status of the HSE and Department of Health assessment of Omaveloxolone (Skyclarys) for the treatment of Friedreich’s Ataxia; the timeline for completing the reimbursement process; the engagement that has taken place with patient representatives and clinical experts; and if she will make a statement on the matter. [18744/26]
1751. Deputy Albert Dolan asked the Minister for Health the specific steps the HSE is taking to ensure that the time-critical nature of Friedreich’s Ataxia is fully recognised and reflected in the ongoing price negotiations for the reimbursement of Skyclarys; and if she will make a statement on the matter. [18745/26]
1752. Deputy Albert Dolan asked the Minister for Health the way in which the commitments set out in the National Rare Disease Strategy 2025–2030, particularly regarding timely access to approved therapies for rare disease patients, are being applied to the current reimbursement process for Skyclarys for the treatment of Friedreich’s Ataxia; and if she will make a statement on the matter. [18746/26]
1753. Deputy Albert Dolan asked the Minister for Health the way in which the 180-day decision timeline contained within the 2026 IPHA Framework Agreement is being implemented in the case of Skyclarys, given that over 570 days have now elapsed since the reimbursement application was submitted; and if she will make a statement on the matter. [18747/26]
73. Deputy Albert Dolan asked the Minister for Health to provide an update on the development of the surgical hub at Galway University Hospital; and if she will make a statement on the matter. [16784/26]
582. Deputy Albert Dolan asked the Minister for Health the number of HSE staff currently on sick leave or stress-related leave, by staff category; and if she will make a statement on the matter. [18110/26]
583. Deputy Albert Dolan asked the Minister for Health the number of cases of bullying reported by HSE staff in the most recent year for which data is available, broken down by hospital group, CHO area and staff category; and if she will make a statement on the matter. [18111/26]
852. Deputy Albert Dolan asked the Minister for Health to list all schemes, funding programmes, capital funds, grant streams or other expenditure headings administered by her Department in 2025 and 2026 which result in allocations, awards, or spending that can be identified with a specific geographical location including county, district, town, or project site, to group these by funding stream or programme heading; t…
853. Deputy Albert Dolan asked the Minister for Health to provide the web link to her Department’s Q4 2025 published report of purchase orders/payments over €20,000, in line with the FOI model publication scheme requirements; the date on which this report was published; and if it has not yet been published, the planned publication date. [16571/26]
854. Deputy Albert Dolan asked the Minister for Health to confirm, in respect of her Department’s published quarterly reports of procurement-related payments or purchase orders over €20,000 (details supplied), where such reports are published in PDF format but originate from an Excel or similar spreadsheet file, that the underlying data was fully expanded and validated prior to conversion so that all columns includin…
1080. Deputy Albert Dolan asked the Minister for Health the timeline for the implementation of screening for spinal muscular atrophy as part of the National Newborn Bloodspot Screening Programme (heel prick test); the specific milestones that have been set for its rollout; the body, agency or individuals responsible for delivery; the reasons for delays in reaching these milestones to date; the actions being taken to …
75. Deputy Albert Dolan asked the Minister for Health to provide an update on the redevelopment of Galway University Hospital; and the current stage of planning and approval, any changes to the project scope or costs; and the anticipated timeline for delivery. [5008/26]
129. Deputy Albert Dolan asked the Minister for Health the actions being taken to increase GP capacity in rural Ireland; whether a dedicated rural GP strategy is in place; and if she will provide details of any timelines or targets. [5009/26]
2217. Deputy Albert Dolan asked the Minister for Health if consideration has been given to disregarding carer's allowance, either in full or in part, for the purposes of secondary benefit assessments such as medical cards; if not, the reasons for same; and if she will make a statement on the matter. [74720/25]
2218. Deputy Albert Dolan asked the Minister for Health the number of discretionary medical cards awarded in the past three years to applicants whose income exceeded the threshold due to receipt of carer's allowance; and if she will make a statement on the matter. [74721/25]
2219. Deputy Albert Dolan asked the Minister for Health if she will review the current medical card income thresholds for those over 70 years of age, particularly in circumstances where household income includes carer's allowance and where there are high, recurring medical expenses; and the proposals to amend the existing assessment criteria. [74722/25]
2463. Deputy Albert Dolan asked the Minister for Health the date on which a supplementary estimate or supplementary estimates was sought in respect of her Department’s Vote for each of the past ten years, and to the date in 2026; the gross and net amount involved in each case; and the Vote subheads to which each supplementary estimate related. [1797/26]
2464. Deputy Albert Dolan asked the Minister for Health the value of expenditure originally allocated in the Estimates to specific programmes or staffing measures that could not be spent as planned within the year for each of the past five years; and whether such underspends were surrendered, carried forward, or reallocated to other areas within the Vote. [1818/26]
438. Deputy Albert Dolan asked the Minister for Health the administrative cost to the Health Service of a missed appointment; if the HSE has carried out any assessments or calculations on same; and if she will make a statement on the matter. [73186/25]
359. Deputy Albert Dolan asked the Minister for Health her response to the newly published report “Unseen and Unregulated: TFA, the ‘forever chemical’ in Europe’s Cereals” (details supplied), which identifies widespread contamination of cereal-based foods across Europe, including samples purchased in Ireland; her intentions to assess the implications for Irish consumers. [70791/25]
360. Deputy Albert Dolan asked the Minister for Health if her Department has carried out an assessment of the potential health risk to children from trifluoroacetic acid exposure in cereal-based foods. [70792/25]
361. Deputy Albert Dolan asked the Minister for Health if she will allocate funding for Irish research into trifluoroacetic acid in food and the environment, given the absence of a national exposure assessment. [70793/25]
362. Deputy Albert Dolan asked the Minister for Health if she will instruct the Food Safety Authority of Ireland to immediately begin national testing of cereal-based foods for trifluoroacetic acid, given the widespread contamination reported across Europe. [70794/25]